PUBLICATION
GLS hyperactivity causes glutamate excess, infantile cataract and profound developmental delay
- Authors
- Rumping, L., Tessadori, F., Pouwels, P.J., Vringer, E., Wijnen, J.P., Bhogal, A.A., Savelberg, S.M., Duran, K.J., Bakkers, M.J., Ramos, R.J., Schellekens, P.A., Kroes, H.Y., Klomp, D.W., Black, G.C., Taylor, R.L., Bakkers, J.P., Prinsen, H.C., Knaap, M.S., Dansen, T.B., Rehmann, H., Zwartkruis, F.J., Houwen, R.H., Haaften, G., Verhoeven-Duif, N.M., Jans, J.J., Hasselt, P.M.
- ID
- ZDB-PUB-180922-9
- Date
- 2018
- Source
- Human molecular genetics 28(1): 96-104 (Journal)
- Registered Authors
- Keywords
- none
- MeSH Terms
-
- Disease Models, Animal
- Glutamate-Ammonia Ligase/genetics
- Glutamate-Ammonia Ligase/physiology
- Humans
- Glutaminase/genetics*
- Glutaminase/physiology*
- Brain/metabolism
- Gain of Function Mutation/genetics
- Fibroblasts
- Animals
- Male
- Child, Preschool
- Cataract/genetics
- Oxidative Stress
- Adolescent
- HEK293 Cells
- Developmental Disabilities/genetics
- Glutamic Acid/genetics
- Glutamic Acid/metabolism
- Female
- Glutamine/metabolism
- Reactive Oxygen Species/metabolism
- Zebrafish
- PubMed
- 30239721 Full text @ Hum. Mol. Genet.
Citation
Rumping, L., Tessadori, F., Pouwels, P.J., Vringer, E., Wijnen, J.P., Bhogal, A.A., Savelberg, S.M., Duran, K.J., Bakkers, M.J., Ramos, R.J., Schellekens, P.A., Kroes, H.Y., Klomp, D.W., Black, G.C., Taylor, R.L., Bakkers, J.P., Prinsen, H.C., Knaap, M.S., Dansen, T.B., Rehmann, H., Zwartkruis, F.J., Houwen, R.H., Haaften, G., Verhoeven-Duif, N.M., Jans, J.J., Hasselt, P.M. (2018) GLS hyperactivity causes glutamate excess, infantile cataract and profound developmental delay. Human molecular genetics. 28(1):96-104.
Abstract
Loss-of-function mutations in glutaminase (GLS), the enzyme converting glutamine into glutamate, and the counteracting enzyme glutamine synthetase (GS) cause disturbed glutamate homeostasis and severe neonatal encephalopathy. We report a de novo Ser482Cys gain-of-function variant in GLS encoding glutaminase associated with profound developmental delay and infantile cataract. Functional analysis demonstrated that this variant causes hyperactivity and compensatory downregulation of GLS expression combined with upregulation of the counteracting enzyme GS, supporting pathogenicity. Ser482Cys-GLS likely improves the electrostatic environment of the GLS catalytic site, thereby intrinsically inducing hyperactivity. Alignment of +/-12.000 GLS protein sequences from >1000 genera, revealed extreme conservation of Ser482, to the same degree as catalytic residues. Together with the hyperactivity, this indicates that Ser482 is evolutionarily preserved to achieve optimal -but submaximal- GLS activity. In line with GLS hyperactivity, increased glutamate and decreased glutamine concentrations were measured in urine and fibroblasts. In the brain (both grey and white matter), glutamate was also extremely high and glutamine almost undetectable, using ultra-high field magnetic resonance spectroscopic imaging. Considering the neurotoxicity of glutamate when present in excess, the strikingly high glutamate concentrations measured in the brain provide an explanation for the developmental delay. Cataract, a known consequence of oxidative stress, was evoked in zebrafish expressing the hypermorphic Ser482Cys-GLS and could be alleviated by inhibition of GLS. The capacity to detoxify reactive oxygen species was reduced upon Ser482Cys-GLS expression, providing an explanation for cataract formation. In conclusion, we describe an inborn error of glutamate metabolism caused by a GLS hyperactivity variant, illustrating the importance of balanced GLS activity.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping